PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer

NCT06074055 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2025-02-07

No results posted yet for this study

Summary

The goal of this randomized clinical trial is to compare frozen embryo transfer protocols in patients undergoing a second frozen embryo transfer (FET) after a unsuccessful first programmed FET cycle as a possible treatment for people undergoing infertility treatment.

The purpose of this research study is to:

* Determine if there is a difference between FET protocols in patients who require a second FET cycle.
* Investigate if switching the FET protocol after a failed programmed cycle is beneficial for patients undergoing a second FET cycle.
* Examine pregnancy outcomes including obstetrical and neonatal outcomes (if applicable)
* Obtain uterine flexibility/stiffness measurements via transvaginal ultrasound prior to the embryo transfer procedure. This is called shear wave elastography.

Participants will be randomized in their second FET transfer attempt to either another programmed protocol or a modified natural protocol.

Conditions

  • Infertility, Female

Interventions

OTHER

FET Protocol

Participants are randomized to either another programmed FET Protocol vs. a modified natural FET protocol

Sponsors & Collaborators

  • Reproductive Medicine Associates of New Jersey

    lead OTHER

Principal Investigators

  • Emre U Seli, MD · Reproductive Medicine Associates of New Jersey

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
53 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-25
Primary Completion
2024-05-10
Completion
2024-10-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06074055 on ClinicalTrials.gov